• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变患者循环miR-320a的下调及靶基因预测

Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy.

作者信息

Prado Marcelle SanJuan Ganem, de Jesus Mirthz Lemos, de Goes Thaline Cunha, Mendonça Lucilla Silva Oliveira, Kaneto Carla Martins

机构信息

Department of Health Science, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.

Department of Biological Science, Universidade Estadual de Santa Cruz, Rodovia Jorge Amado, Km16, Ilhéus, BA, 45662-900, Brazil.

出版信息

BMC Res Notes. 2020 Mar 16;13(1):155. doi: 10.1186/s13104-020-05001-9.

DOI:10.1186/s13104-020-05001-9
PMID:32178730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7077016/
Abstract

OBJECTIVE

To evaluate the expression of a set of miRNAs to identify differentially expressed miRNAs that might be considered reliable biomarkers on Diabetic Retinopathy (DR) blood samples.

RESULTS

Expression levels of MiR-320a, MiR-342-3p, MiR-155, MiR-99a, MiR-29a and MiR-27b were analyzed in 60 healthy controls, 48 Diabetes Melitus (DM) without DR patients and 62 DR patients by qRT-PCR. MiR-320a was shown to be downregulated in the plasma of DR patients compared with DM patients without DR and healthy subjects. Target genes were predicted using miRWalk3.0, miR targeting data and target gene interaction data were imported to Cytoscape to visualize and merge networks and top ranked predicted genes were run through Ontology Genes to perform enrichment analysis on gene sets and classification system to identify biological processes and reactome pathways associated with DR. Highly scored target genes of miR-320a were categorized for various biological processes, including negative regulation of cell aging, negative regulation of cellular protein metabolic process and regulation of cellular response to stress that are critical to the development of DR. Our findings suggest that MiR-320a may have a role in the pathogenesis of DR and may represent novel biomarkers for this disease.

摘要

目的

评估一组微小RNA(miRNA)的表达,以鉴定在糖尿病视网膜病变(DR)血样中可能被视为可靠生物标志物的差异表达miRNA。

结果

通过qRT-PCR分析了60名健康对照者、48名无DR的糖尿病(DM)患者和62名DR患者中MiR-320a、MiR-342-3p、MiR-155、MiR-99a、MiR-29a和MiR-27b的表达水平。与无DR的DM患者和健康受试者相比,DR患者血浆中MiR-320a表达下调。使用miRWalk3.0预测靶基因,将miR靶向数据和靶基因相互作用数据导入Cytoscape以可视化和合并网络,并对排名靠前的预测基因通过本体基因进行基因集富集分析和分类系统分析,以识别与DR相关的生物学过程和反应组途径。miR-320a的高分靶基因被归类为各种生物学过程类别,包括对细胞衰老的负调控、细胞蛋白质代谢过程的负调控以及对细胞应激反应的调控,这些对DR的发展至关重要。我们的研究结果表明,MiR-320a可能在DR的发病机制中起作用,并且可能代表该疾病的新型生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/7077016/0f46a4f313ec/13104_2020_5001_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/7077016/0e2510e74cb5/13104_2020_5001_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/7077016/0f46a4f313ec/13104_2020_5001_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/7077016/0e2510e74cb5/13104_2020_5001_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11fd/7077016/0f46a4f313ec/13104_2020_5001_Fig2_HTML.jpg

相似文献

1
Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy.糖尿病视网膜病变患者循环miR-320a的下调及靶基因预测
BMC Res Notes. 2020 Mar 16;13(1):155. doi: 10.1186/s13104-020-05001-9.
2
Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy.循环 miR-3197 和 miR-2116-5p 作为糖尿病视网膜病变的新型生物标志物。
Clin Chim Acta. 2020 Feb;501:147-153. doi: 10.1016/j.cca.2019.10.036. Epub 2019 Oct 31.
3
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes.与 2 型糖尿病患者视网膜病变相关的血浆 microRNA 特征。
Sci Rep. 2021 Feb 18;11(1):4136. doi: 10.1038/s41598-021-83047-w.
4
Identification of miR-328-3p as an endogenous reference gene for the normalization of miRNA expression data from patients with Diabetic Retinopathy.鉴定 miR-328-3p 作为糖尿病视网膜病变患者 miRNA 表达数据归一化的内参基因。
Sci Rep. 2019 Dec 23;9(1):19677. doi: 10.1038/s41598-019-56172-w.
5
MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy.miR-1281 作为糖尿病视网膜病变患者的新型循环生物标志物。
Front Endocrinol (Lausanne). 2020 Aug 4;11:528. doi: 10.3389/fendo.2020.00528. eCollection 2020.
6
RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.RNA 测序鉴定出用于糖尿病视网膜病变早期检测的特定循环 miRNA 生物标志物。
Am J Physiol Endocrinol Metab. 2018 Sep 1;315(3):E374-E385. doi: 10.1152/ajpendo.00021.2018. Epub 2018 May 29.
7
Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.血清 miR-20b、miR-17-3p、HOTAIR 和 MALAT1 在糖尿病视网膜病变中的诊断和预后作用。
IUBMB Life. 2019 Mar;71(3):310-320. doi: 10.1002/iub.1970. Epub 2018 Nov 23.
8
Elevated Plasma Levels of Circulating Extracellular miR-320a-3p in Patients with Paroxysmal Atrial Fibrillation.阵发性心房颤动患者循环细胞外 miR-320a-3p 水平升高。
Int J Mol Sci. 2020 May 15;21(10):3485. doi: 10.3390/ijms21103485.
9
Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine.接受右美托咪定治疗患者的循环miRNA表达谱分析及靶标预测
Cell Physiol Biochem. 2018;50(2):552-568. doi: 10.1159/000494168. Epub 2018 Oct 11.
10
Circulating miRNAs as biomarkers for severe acute pancreatitis associated with acute lung injury.循环 miRNA 作为与急性肺损伤相关的重症急性胰腺炎的生物标志物。
World J Gastroenterol. 2017 Nov 7;23(41):7440-7449. doi: 10.3748/wjg.v23.i41.7440.

引用本文的文献

1
Identification of SnRNA U6 as an endogenous reference gene for normalization of MiRNA expression data in COVID-19 patients.鉴定小核仁RNA U6作为COVID-19患者中miRNA表达数据标准化的内参基因。
Sci Rep. 2025 Jul 22;15(1):26636. doi: 10.1038/s41598-025-04062-9.
2
Breakthroughs in diabetic retinopathy diagnosis and treatment using preclinical research models: current progress and future directions.使用临床前研究模型进行糖尿病视网膜病变诊断和治疗的突破:当前进展与未来方向
Ann Med. 2025 Dec;57(1):2531251. doi: 10.1080/07853890.2025.2531251. Epub 2025 Jul 13.
3
Epigenetic Regulation of Sorbitol Dehydrogenase in Diabetic Retinopathy Patients: DNA Methylation, Histone Acetylation and microRNA-320.

本文引用的文献

1
Identification of miR-328-3p as an endogenous reference gene for the normalization of miRNA expression data from patients with Diabetic Retinopathy.鉴定 miR-328-3p 作为糖尿病视网膜病变患者 miRNA 表达数据归一化的内参基因。
Sci Rep. 2019 Dec 23;9(1):19677. doi: 10.1038/s41598-019-56172-w.
2
Circulating miRNAs as biomarkers in cardiovascular diseases.循环 miRNA 作为心血管疾病的生物标志物。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2234-2243. doi: 10.26355/eurrev_201903_17271.
3
Down-regulation of miR-377 suppresses high glucose and hypoxia-induced angiogenesis and inflammation in human retinal endothelial cells by direct up-regulation of target gene SIRT1.
糖尿病视网膜病变患者中山梨醇脱氢酶的表观遗传调控:DNA甲基化、组蛋白乙酰化和微小RNA-320
Biologics. 2025 Apr 28;19:251-264. doi: 10.2147/BTT.S521519. eCollection 2025.
4
Advances in Research Related to MicroRNA for Diabetic Retinopathy.糖尿病视网膜病变的微小RNA相关研究进展
J Diabetes Res. 2024 Feb 12;2024:8520489. doi: 10.1155/2024/8520489. eCollection 2024.
5
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.糖尿病血脂异常相关的微小囊泡和循环 microRNAs:miR-218、miR-132、miR-143 和 miR-21、miR-122、miR-155 具有生物标志物潜力。
Cardiovasc Diabetol. 2023 Sep 25;22(1):260. doi: 10.1186/s12933-023-01988-0.
6
Regulation of Long Noncoding RNA NEAT1/miR-320a/HIF-1α Competitive Endogenous RNA Regulatory Network in Diabetic Retinopathy.调控长链非编码 RNA NEAT1/miR-320a/HIF-1α 竞争性内源性 RNA 调控网络在糖尿病视网膜病变中的作用。
Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):11. doi: 10.1167/iovs.64.10.11.
7
Circulating salivary and serum miRNA-182, 320a, 375 and 503 expression levels in type 2 diabetes.2型糖尿病患者循环唾液和血清中miRNA-182、320a、375和503的表达水平
J Diabetes Metab Disord. 2022 Jul 28;21(2):1469-1478. doi: 10.1007/s40200-022-01082-4. eCollection 2022 Dec.
8
Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery.糖尿病中miRNA和lncRNA失调的当前见解:信号转导、临床试验与生物标志物发现
Pharmaceuticals (Basel). 2022 Oct 14;15(10):1269. doi: 10.3390/ph15101269.
9
LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis.长链非编码RNA LINC00680作为竞争性内源性RNA并与重症肌无力的严重程度相关。
Front Neurol. 2022 Jun 21;13:833062. doi: 10.3389/fneur.2022.833062. eCollection 2022.
10
Identification of miRNA-mRNA-TF regulatory networks in peripheral blood mononuclear cells of type 1 diabetes.鉴定 1 型糖尿病患者外周血单个核细胞中的 miRNA-mRNA-TF 调控网络。
BMC Endocr Disord. 2022 May 9;22(1):119. doi: 10.1186/s12902-022-01038-y.
下调 miR-377 通过直接上调靶基因 SIRT1 抑制高糖和低氧诱导的人视网膜内皮细胞血管生成和炎症反应。
Hum Cell. 2019 Jul;32(3):260-274. doi: 10.1007/s13577-019-00240-w. Epub 2019 Jan 31.
4
Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects.糖尿病患者合并与不合并视网膜病变以及健康受试者循环细胞外囊泡的分子和功能特征。
Exp Eye Res. 2018 Nov;176:69-77. doi: 10.1016/j.exer.2018.07.003. Epub 2018 Jul 3.
5
Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes.与 1 型糖尿病患者高血糖相关的循环 miRNA 谱。
Diabetes. 2018 May;67(5):1013-1023. doi: 10.2337/db17-1207. Epub 2018 Feb 16.
6
MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophy.微小RNA分析鉴定出miR-7-5p和miR-26b-5p在伴有左心室肥厚的高血压患者中存在差异表达。
Braz J Med Biol Res. 2017 Oct 19;50(12):e6211. doi: 10.1590/1414-431X20176211.
7
MicroRNA-200b Expression in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy.增殖性糖尿病视网膜病变患者玻璃体液中MicroRNA-200b的表达
Ophthalmic Res. 2017;58(3):168-175. doi: 10.1159/000475671. Epub 2017 Jun 2.
8
Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus.糖尿病视网膜病变患者与2型糖尿病患者血清微小RNA表达谱的比较。
Clinics (Sao Paulo). 2017 Feb 1;72(2):111-115. doi: 10.6061/clinics/2017(02)08.
9
Diabetic Retinopathy: A Position Statement by the American Diabetes Association.糖尿病视网膜病变:美国糖尿病协会的立场声明。
Diabetes Care. 2017 Mar;40(3):412-418. doi: 10.2337/dc16-2641.
10
Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice.治疗性miR-21沉默改善小鼠糖尿病肾病
Mol Ther. 2017 Jan 4;25(1):165-180. doi: 10.1016/j.ymthe.2016.08.001.